Spots Global Cancer Trial Database for The Roles of Tissue Factor in Malignant Gliomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Roles of Tissue Factor in Malignant Gliomas
Official Title: The Roles of Tissue Factor in Malignant Gliomas
Study ID: NCT00201903
Interventions
Study Description
Brief Summary: To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma
Detailed Description: To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Henry Ford Hospital, Detroit, Michigan, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Cross Cancer Institute, Edmonton, Alberta, Canada
CancerCare Manitoba, Winnipeg, Manitoba, Canada
Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
Princess Margaret Hospital, Toronto, Ontario, Canada
Contact Details
Name: Agnes Lee, MD
Affiliation: Hamilton Health Sciences and McMaster University
Role: STUDY_CHAIR
Name: William Geerts, MD
Affiliation: Sunnybrook Health Sciences Centre
Role: PRINCIPAL_INVESTIGATOR
Name: Mark Levine, MD
Affiliation: Ontario Clinical Oncology Group (OCOG)
Role: PRINCIPAL_INVESTIGATOR
Name: James Perry, MD
Affiliation: Toronto Sunnybrook Regional Cancer Centre
Role: PRINCIPAL_INVESTIGATOR
Name: Janusz Rak
Affiliation: Hamilton Health Sciences and McMaster University
Role: PRINCIPAL_INVESTIGATOR
Name: Jeffrey Weitz, MD
Affiliation: Hamilton Health Sciences and McMaster University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
